| Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis P Sort, M Navasa, V Arroyo, X Aldeguer, R Planas, L Ruiz-del-Arbol, ... New England Journal of Medicine 341 (6), 403-409, 1999 | 2047 | 1999 |
| Hepatitis C virus antibodies among risk groups in Spain JI Esteban, L Viladomiu, A Gonzalez, M Roget, J Genesca, R Esteban, ... The Lancet 334 (8658), 294-297, 1989 | 1228 | 1989 |
| A placebo-controlled trial of obeticholic acid in primary biliary cholangitis F Nevens, P Andreone, G Mazzella, SI Strasser, C Bowlus, P Invernizzi, ... New England Journal of Medicine 375 (7), 631-643, 2016 | 1093 | 2016 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1044 | 2019 |
| Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis J Fernández, M Navasa, R Planas, S Montoliu, D Monfort, G Soriano, ... Gastroenterology 133 (3), 818-824, 2007 | 879 | 2007 |
| Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double‐blind, placebo‐controlled trial P Ginés, A Rimola, R Planas, V Vargas, F Marco, M Almela, M Forne, ... Hepatology 12 (4), 716-724, 1990 | 789 | 1990 |
| Systemic inflammation in decompensated cirrhosis: characterization and role in acute‐on‐chronic liver failure J Clària, RE Stauber, MJ Coenraad, R Moreau, R Jalan, M Pavesi, ... Hepatology 64 (4), 1249-1264, 2016 | 708 | 2016 |
| Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis A Ginés, G Fernandez-Esparrach, A Monescillo, C Vila, E Domenech, ... Gastroenterology 111 (4), 1002-1010, 1996 | 706 | 1996 |
| Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease YI Duan, C Llorente, S Lang, K Brandl, H Chu, LU Jiang, RC White, ... Nature 575 (7783), 505-511, 2019 | 567 | 2019 |
| Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide S Piano, V Singh, P Caraceni, R Maiwall, C Alessandria, J Fernandez, ... Gastroenterology 156 (5), 1368-1380. e10, 2019 | 397 | 2019 |
| Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis M Navasa, A Follo, JM Llovet, G Clemente, V Vargas, A Rimola, F Marco, ... Gastroenterology 111 (4), 1011-1017, 1996 | 383 | 1996 |
| Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites P Ginès, V Arroyo, V Vargas, R Planas, F Casafont, J Panés, M Hoyos, ... New England Journal of Medicine 325 (12), 829-835, 1991 | 366 | 1991 |
| Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma JM Llovet, M Sala, L Castells, Y Suarez, R Vilana, L Bianchi, C Ayuso, ... Hepatology 31 (1), 54-58, 2000 | 348 | 2000 |
| Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial A Mas, J Rodés, L Sunyer, L Rodrigo, R Planas, V Vargas, L Castells, ... Journal of hepatology 38 (1), 51-58, 2003 | 344 | 2003 |
| The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 73 (4), 842-854, 2020 | 337 | 2020 |
| The development of low-grade cerebral edema in cirrhosis is supported by the evolution of 1H-magnetic resonance abnormalities after liver transplantation J Córdoba, J Alonso, A Rovira, C Jacas, F Sanpedro, L Castells, V Vargas, ... Journal of hepatology 35 (5), 598-604, 2001 | 298 | 2001 |
| Quality of life and cognitive function in hepatitis C at different stages of liver disease J Córdoba, M Flavià, C Jacas, S Sauleda, JI Esteban, V Vargas, ... Journal of hepatology 39 (2), 231-238, 2003 | 278 | 2003 |
| Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study A Rimola, JM Salmerón, G Clemente, L Rodrigo, A Obrador, LM Miranda, ... Hepatology 21 (3), 674-679, 1995 | 260 | 1995 |
| Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe J Fernández, V Prado, J Trebicka, A Amoros, T Gustot, R Wiest, ... Journal of hepatology 70 (3), 398-411, 2019 | 254 | 2019 |
| Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF R Moreau, J Clària, F Aguilar, F Fenaille, JJ Lozano, C Junot, B Colsch, ... Journal of hepatology 72 (4), 688-701, 2020 | 251 | 2020 |
